61
Views
10
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

Drug treatment utilization before, during and after pregnancy

, , , &
Pages 27-38 | Published online: 12 Jul 2009

References

  • Birchfield M., Scully J., Handler A. Perinatal screening for illicit drugs: Policies in hospitals in a large metropolitan area. Journal of Perinatology 1995; 15((3))208–214
  • Breitbart V., Chavkin W., Wise P. The accessibility of drug treatment for pregnant women: A survey of programs in five cities. American Journal of Public Health 1994; 84: 1658–1661
  • Brindis C., Berkowitz G., Clayson Z. Options for recovery: Promoting perinatal drug and alcohol recovery, child health, and family stability. Journal of Drug Issues 1997; 27: 607–624
  • California Department of Alcohol and Drug Programs. The history of perinatal substance abuse services in California. CDADP, Sacramento 2000a, Fact Sheet
  • California Department of Alcohol and Drug Programs. Perinatal programs: Alcohol and drug services. CDADP, Sacramento 2000b, Fact Sheet
  • Center for Substance Abuse Treatment. Benefits of residential substance abuse treatment for pregnant and parenting women: Highlights from a study of 50 center for substance abuse treatment demonstration programs. Substance Abuse and Mental Health Services Administration, Washington,DC 2001
  • Chasnoff I. J., Landress H. J., Barrett M. E. The prevalence of illicit‐drug or alcohol use during pregnancy and discrepancies in mandatory reporting in Pinellas County, Florida. New England Journal of Medicine 1990; 322: 1202–1206
  • Chavkin W. Drug addiction and pregnancy: Policy crossroads. American Journal of Public Health 1990; 80: 483–487
  • Eisen M., Keyser‐Smith J., Dampeer J., Sambrano S. Evaluation of substance use outcomes in demonstration projects for pregnant and postpartum women and their infants: Findings from a quasi‐experiment. Addictive Behaviors 2000; 25: 123–129
  • Gehshan S. Missed opportunities for intervening in the lives of pregnant women addicted to alcohol or other drugs. JAMWA 1995; 50((5))160–163
  • Grella C. Women in residential drug treatment: Differences by program type and pregnancy. Journal of Health Care for the Poor and Underserved 1999; 10((2))216–229
  • Guydish J., Moore L., Gleghorn A., Davis T., Sears C., Harcourt J. Drug abuse treatment on demand in San Francisco: Preliminary findings. Journal of Psychoactive Drugs 2000; 32((4))363–370
  • Howell E., Heiser N., Harrington M. A review of recent findings on substance abuse treatment for pregnant women. Journal of Substance Abuse Treatment 1999; 16((3))195–219
  • Howell E. M., Chasnoff I. J. Perinatal substance abuse treatment. Findings from focus groups with clients and providers. Journal of Substance Abuse Treatment 1999; 17: 139–148
  • Kelly R., Zatzick D., Anders T. The detection and treatment of psychiatric disorders and substance use among pregnant women cared for in obstetrics. American Journal of Psychiatry 2001; 158: 213–219
  • Klein D., Zahnd E. Perspectives of pregnant substance‐using women: Findings from the California perinatal needs assessment. Journal of Psychoactive Drugs 1997; 29: 55–66
  • Lester, B., Andreozzi, L., & Appiah, L. (2004). Substance use during pregnancy: Time for policy to catch up with research. Available at: www.harmreductionjournal.com/content/1/1/5.
  • Lester B., ElSohly M., Wright L., Smeriglio V., Verter J., Bauer C., et al. The maternal lifestyle study: Drug use by meconium toxicology and maternal self report. Pediatrics 2001; 107: 309–317
  • Marsh J., D'Aunno T., Smith B. Increasing access and providing social services to improve drug abuse treatment for women with children. Addiction 2000; 95: 1237–1247
  • Mitchell J. Pregnant, substance‐using women: Treatment improvement protocol (tip) series. Center for Substance Abuse Treatment, DHHS, Rockville 1993, No. (SMA) 93‐1998
  • National Center on Addiction and Substance Abuse. Substance abuse and the American woman. Columbia University, New York 1996
  • National Evaluation Data Services. Effectiveness of women's substance abuse treatment programs: A meta‐analysis. Center for Substance Abuse Treatment, Arlington 2001
  • National Household Survey on Drug Abuse. Pregnancy and illicit drug use. NHSDA Report 2001; 1–3
  • Practice Management Information Corporation. International classification of diseases. Practice Management Information Corporation, Los Angeles 1997, 9th revision, Clinical modification, 5th edn
  • Puentes A. System responses to perinatal addiction. Pregnancy and exposure to alcohol and other drug use, D Kronstadt, P Green, C Marcus. Center for Substance Abuse Prevention, Rockville 1993; 7–46, Vol. 7
  • Saitz R., Mulvey K., Plough A., Samet J. Physician unawareness of serious substance abuse. American Journal of Drug and Alcohol Abuse 1997; 23: 343–354
  • Samet J., Rollnick S., Barnes H. Beyond cage: A brief clinical approach after detection of substance abuse. Archives of Internal Medicine 1996; 156: 2287–2293
  • SAS Institute Inc. SAS software (Version 8.2). SAS Institute Inc, Cary 2004
  • Simpson D. Treatment for drug abuse: Follow‐up outcomes and length of time spent. Archives of General Psychiatry 1981; 38: 875–880
  • Statacorp. Stata statistical software: Release 8.0. Stata Corporation, College Station, Texas 2003
  • Uziel‐Miller N., Lyons J. Specialized substance abuse treatment for women and their children: An analysis of program design. Journal of Substance Abuse Treatment 2000; 19: 355–367
  • Vega W., Kolody B., Hwang J., Noble A. Prevalence and magnitude of perinatal substance exposures in California. New England Journal of Medicine 1993; 329: 850–854
  • Wexler H., Cuadrado M., Stevens S. Residential treatment for women: Behavioral and psychological outcomes. Women and substance abuse: Gender transparency, S Stevens, H Wexler. Haworth Press, Inc, New York 1998; 213–233
  • Zellman G., Fair C., Hoube J., Wong M. A search for guidance: Examining prenatal substance exposure protocols. Maternal and Child Health Journal 2002; 6((3))205–212

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.